Tanya Binette | Director, Drug Development Services - Rare Diseases
ICON plc

Tanya Binette is a rare disease strategy expert, bringing patient-centric and rare-specific strategies to study teams and customers, supporting from preclinical through commercialization and across therapeutic areas. She has more than 17 years of strategy development and project management experience in the clinical research industry. Her rare disease experience includes over 2 years as a Director of Therapeutic Expertise in ICON's Centre for Rare Diseases and operational experienc in rare disease clinical trials as a Clnical Trial Liaison. Her previous roles in strategic planning and communication within the CRO/pharma industry span all therapeutic areas and include proposal strategy development, medical writing, proposal writing, and feasibility study development, management, and reporting. Her academic qualifications include a PhD in experimental surgery and a postdoctoral fellowship in biochemistry.